Ellomay Capital (NYSEAMERICAN:ELLO – Get Free Report) posted its quarterly earnings data on Sunday. The utilities provider reported ($0.34) earnings per share for the quarter, reports. The company had revenue of $8.91 million during the quarter. Ellomay Capital had a net margin of 3.24% and a return on equity of 3.01%.
Ellomay Capital Stock Down 0.4 %
Shares of ELLO opened at $12.08 on Wednesday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 3.16. The firm has a market cap of $155.23 million, a price-to-earnings ratio of 38.60 and a beta of 1.25. Ellomay Capital has a 12 month low of $10.00 and a 12 month high of $20.26.
Hedge Funds Weigh In On Ellomay Capital
An institutional investor recently raised its position in Ellomay Capital stock. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of Ellomay Capital Ltd. (NYSEAMERICAN:ELLO – Free Report) by 54.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,512,554 shares of the utilities provider’s stock after purchasing an additional 534,554 shares during the quarter. Clal Insurance Enterprises Holdings Ltd owned about 11.77% of Ellomay Capital worth $22,580,000 at the end of the most recent reporting period. 27.54% of the stock is currently owned by hedge funds and other institutional investors.
Ellomay Capital Company Profile
Ellomay Capital Ltd., together with its subsidiaries, engages in the initiation, development, construction, and production of renewable and clean energy projects in Spain, the United States, Italy, the Netherlands, and Israel. The company owns photovoltaic (PV) plants comprising five PV plants in Spain with an aggregate installed capacity of approximately 35.9 megawatts (MW); and one PV plant with an installed capacity of 300 MW in the municipality of Talaván, Spain.
Read More
- Five stocks we like better than Ellomay Capital
- Why Are Stock Sectors Important to Successful Investing?
- Does BJ’s Wholesale Club Stock Have More Room to Grow?
- What is MarketRank™? How to Use it
- Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
- Golden Cross Stocks: Pattern, Examples and Charts
- RXO Shares Surge Following New Acquisition Deal
Receive News & Ratings for Ellomay Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellomay Capital and related companies with MarketBeat.com's FREE daily email newsletter.